关于抗癌性质的thiosemicarbazide和semicarbazide衍生物之间的ADMET概况的比较
Łucja Justyna Walczak1, Mariola Herbet1
1Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, Lublin, Poland.
Expert opinion on drug metabolism & toxicology
|June 13, 2025
概括
半碳化物作为抗癌药物表现有前途,原因是与硫化物相比,它们的吸收性更好,毒性更低. 这次审查分析了他们的ADMET资料,以改进癌症治疗方法.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症发病率不断上升,需要新的治疗药物.
- 目前的化疗药物 (细胞静止剂) 具有有限的疗效和显著的不良影响.
- 西米卡巴和半卡巴衍生物正在成为潜在的抗癌药物候选者.
研究的目的:
- 进行吸收,分布,新陈代谢,分泌和毒性 (ADMET) 档案的系统审查和比较分析.
- 为了评估具有记录的抗瘤活性的 thiosemicarbazides 和 semicarbazides.
- 为开发更安全,更有效的抗癌疗法提供信息.
主要方法:
- 在PubMed,ScienceDirect和谷歌学者数据库中进行系统的文献搜索.
- 使用ADMETlab 2.0软件对合格化合物进行in silicoADMET分析.
- 统计分析包括学生的t测试,曼-惠特尼U测试和千二测试.
主要成果:
- 半碳化物表现出优越的肠道吸收,更高的选择性和药物相互作用的风险降低,尽管生物活性较低.
- 西米卡巴化物表现出更高的代谢活性,更高的毒性,更强的血蛋白结合,更低的未结合分数和更长的半衰期.
- 对比分析突出了ADMET独特的特征,影响了治疗潜力.
结论:
- 西米卡巴化物可能会诱导氧化应激和DNA损伤,这是癌症治疗中的相关机制.
- 半碳化物是临床抗癌试验中更有利的候选物,原因是改善了药理动力学和药理动力学特性,并降低了毒性.
- 这些发现指导了为未来药物开发选择有前途的半碳酸衍生物的选择.
相关概念视频
Structure-Activity Relationships and Drug Design
677
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
677
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Antihypertensive Drugs: Thiazide-Class Diuretics
560
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
560
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
237
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
237
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


